Pandeia Therapeutics Limited
11463856
Healthy
- Negative net worth (-10)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 26/06/2025
Due 10/07/2026
Industry
Officers
director · Since 26/04/2024
COMPANY DIRECTOR
AMERICAN · UNITED STATES · Age 56
Also on 1 other board
Persons with Significant Control
Acadia Pharmaceuticals Inc.
12830, El Camino Real, San Diego
Notified 22/12/2022
Former PSCs
Dr Timothy Schulz-Utermoehl
Ceased 20/09/2019
Dr Fraser Murray
Ceased 05/03/2019
Mr Martin Quibell
Ceased 05/03/2019
Medicxi Ventures I Lp
Ceased 22/12/2022
CompanyRankvs 1546+ SIC 72110 peers51
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
-£3.2M
Balance sheet strength
Cash
£223k
Cash in the bank
Net Current Assets
£142k
Working capital
Current Assets
£270k
Current Liabilities
£128k
Debtors
£48k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 2.11 | -£1.9M |
| 2023 | 2.70 | -£1.3M |
| 2022 | 4.34 | +£0 |
| 2021 | 15.00 | +£2k |
| 2020 | 6.54 | +£845 |
| 2019 | 9.94 | — |
Derived from filed accounts. Not audited figures.